First-in-human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS-986177/JNJ-70033093, a direct, reversible, small molecule Factor XIa inhibitor in healthy volunteers

Authors: V Perera, Z Wang, J Luettgen, J Wang, D Li, M Desouza, M Cerra, D Seiffert

Published: 2020-11-26

DOI: 10.1093/ehjci/ehaa946.3362

Source: Full article